{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-029700","form_type":"8-K","ticker":"ELTP","cik":"0001053369","company_name":"ELITE PHARMACEUTICALS INC /NV/","filed_at":"2026-06-23T11:02:37+00:00","discovered_at":"2026-06-23T11:05:00.247242+00:00","generated_at":"2026-06-23T11:05:12.804002+00:00","sec_items":["7.01","2.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Elite Pharmaceuticals to release FY2026 results on June 29, host call on June 30","bullets":["FY2026 (ended March 31, 2026) financial results to be released Monday, June 29, 2026.","Conference call Tuesday, June 30, 2026 at 11:30 AM EDT; dial-in 1-800-346-7359, conference code 98840.","General questions due by 5:00 PM EDT on June 26; financial questions by 7:00 PM EDT on June 29.","Management will provide a corporate update and discuss results during the call."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-029700","json":"https://secwatch.observer/filing/0001493152-26-029700.json","markdown":"https://secwatch.observer/filing/0001493152-26-029700.md","text":"https://secwatch.observer/filing/0001493152-26-029700.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1053369/000149315226029700/0001493152-26-029700-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1053369/000149315226029700/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T11:05:12.804002+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}